Walder Wyss advised Adjuvant Capital.Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the close of an oversubscribed Series B financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
